CONVERGENT VALIDITY OF NEW DISEASE ASSESSMENT INSTRUMENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN RELATION TO BILAG-2004
Author(s)
Collins CE1, Hautamaki E2, Narayanan S2, Busch HM3, Lamichhane D1, Woodruff L4, Gaylis N5, Chatham WW6
1MedStar Washington Hospital Center, Washington, DC, USA, 2Ipsos Healthcare, Washington, DC, USA, 3Science & Research Institute, Inc., Jupiter, FL, USA, 4University of Alabama, Birmingham, Birmingham, AL, USA, 5Arthritis and Rheumatic Disease Specialties, Aventura, FL, USA, 6University of Alabama, Birmingham, AL, USA
OBJECTIVES: Current validated DAIs in SLE require disease expertise and/or involve complex scoring systems, and are often impractical for use in daily clinical practice. In an attempt to address this issue, several new simplified DAIs in SLE are in different stages of development, including SLE Activity Tracking Evaluation Tool (LAST), Clinical LAST (C-LAST), Total Lupus Activity Score (TLAS), Simple Disease Assessment for People with Lupus Erythematosus (SIMPLE) and Physician Global Assessments (PhGA) (Arthritis Rheumatol.
Conference/Value in Health Info
2016-05, ISPOR 2016, Washington DC, USA
Value in Health, Vol. 19, No. 3 (May 2016)
Code
PRM31
Topic
Clinical Outcomes, Methodological & Statistical Research
Topic Subcategory
Clinical Outcomes Assessment, PRO & Related Methods
Disease
Systemic Disorders/Conditions